Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients.

Nickel, P; Schürmann, M; Albrecht, H; Schindler, R; Budde, K; Westhoff, T; Millward, J; Suttorp, N; Reinke, P; Schürmann, D

Nickel, P; Schürmann, M; Albrecht, H; Schindler, R; Budde, K; Westhoff, T; Millward, J; Suttorp, N; Reinke, P; Schürmann, D.

Affiliation

Nickel P; Division of Nephrology and Intensive Care, Department of Internal Medicine, Campus Virchow-Klinikum, Charité-University Medicine Berlin, Berlin, Germany.

Infection ; 42(6): 981-9, 2014 Dec.

Article in En | MEDLINE | ID: mdl-25168263

Subject(s)

Antifungal Agents/therapeutic use; Clindamycin/therapeutic use; Kidney Transplantation; Pneumocystis carinii/isolation & purification; Pneumonia, Pneumocystis/drug therapy; Primaquine/therapeutic use; Adult; Aged; Cohort Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Pneumocystis / Primaquine / Clindamycin / Kidney Transplantation / Pneumocystis carinii / Antifungal Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Infection Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google